Business ❯ Biotechnology

Acquisitions

Mergers and Acquisitions Pharmaceuticals Company Sales Corporate Strategy Mergers Curevac Corporate Transactions Gilead Sciences Genmab Investment Gene Editing Johnson & Johnson Data Privacy

Pfizer Wins Metsera With $10 Billion Cash‑Plus‑CVR Offer as Novo Withdraws

Metsera said a call from the FTC about antitrust risks in a rival’s bid drove its switch.

Genmab to Buy Merus for $8 Billion to Secure Petosemtamab Cancer Drug

Roche to Acquire 89bio in Deal Worth Up to $3.5 Billion

Kite Pharma to Buy Interius for $350 Million, Adding In‑Vivo CAR‑T Platform

Sanofi Signs $1.15 Billion Deal to Acquire Vicebio’s Molecular Clamp Respiratory Vaccine Platform

Eli Lilly to Acquire Verve Therapeutics for $1.3 Billion